1. OneMedNet reduced liabilities by 75%, improving financial stability. 2. A partnership with Palantir accelerates platform development for real-world data. 3. Demand for real-world data is increasing, boosting subscription-based revenue. 4. Plans for 2026 include expanding services and improving data analysis tools. 5. OneMedNet's innovations position it to capture significant healthcare market opportunities.
FAQ
Why Bullish?
The reduction of liabilities and strategic partnerships enhance OneMedNet’s market position. Previous announcements by similar companies during partnerships often led to price increases.
How important is it?
The article provides detailed insights into financial improvements and strategic partnerships, directly indicating potential for ONMD's growth.
Why Long Term?
The increased stability and expansion plans position OneMedNet for sustained growth, with examples like Palantir’s partnership resulting in long-term gains.
OneMedNet CEO Aaron Green Shares Vision for 2025 in Shareholder Letter
MINNEAPOLIS, Dec. 22, 2025 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD), a frontrunner in delivering regulatory-grade Real-World Data (RWD), has issued a comprehensive letter from President and CEO Aaron Green to its shareholders and stakeholders, outlining key achievements and strategic plans for the company moving forward.
2025: A Year of Strategic Focus
In his letter, Green emphasized that 2025 was pivotal for OneMedNet, highlighting three main areas of concentration: platform development, workforce enhancement, and the execution of their strategic objectives. With the recent selection of Palantir’s AI platform in October 2025, the company is poised to launch an AI-driven multimodal subscription search system in the upcoming year, expected to transform how life sciences organizations interact with vital data.
Key Highlights from 2025
- Financial Strength: Reduced total liabilities by approximately $19.6 million, achieving a 75% reduction by the end of 2025 compared to December 31, 2024.
- Platform Development: Accelerated integration of Palantir (PLTR) into OneMedNet's offerings.
- Network Expansion: Increased healthcare provider network by 37% year-over-year, totaling 186 million clinical exams across over 2,130 partner sites.
- Team Growth: Expanded commercial and operational teams to enhance business capabilities.
What Sets OneMedNet Apart?
OneMedNet differentiates itself with its proven success and innovative technology, including:
- Proven Customer Success: Enhanced contracts and repeat business from leading healthcare organizations.
- AI-Powered Data Access: Utilizing Palantir's advanced platform for real-time access to curated datasets for drug development and regulatory needs.
- Longitudinal Patient Records: Offering data that tracks patient journeys and updates in real-time, providing a competitive edge over stagnant data solutions.
- Multimodal iRWD™: Integrating various data types for a comprehensive view of patient health and tailored research datasets.
Opportunities and Market Trends
Looking ahead, OneMedNet is strategically positioned to capitalize on emerging market trends, including:
- Increasing Demand for RWD: A notable shift towards large-scale RWD for AI model training and validation.
- Platform Expansion Strategy: Plans to roll out additional services in 2026 to support healthcare data analysis.
- Regulatory Shifts: Broadening acceptance of Real-World Evidence (RWE) in regulatory processes by organizations like the FDA and EMA.
- Unlocking Market Potential: Positioned to tap into the estimated $868 billion AI-driven healthcare market by 2030.
Commitment to Shareholders and Future Growth
Green concluded his letter by reaffirming OneMedNet’s commitment to delivering value through their transformative platform. The company’s focus on removing barriers between healthcare providers and researchers positions them for rapid growth and the adoption of their innovative RWD solutions.
For more information on OneMedNet's financial performance and strategic initiatives, visit their Investor Relations page.
About OneMedNet Corporation
OneMedNet is at the forefront of harnessing Real-World Data, leveraging a vast network of over 2,130 healthcare sites through its proprietary iRWD™ platform. This innovative approach supports advancements in drug development and healthcare solutions while also providing cross-industry applications in finance and retail.